- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- Ha Noi Vietnam
- IPO Date
- Aug 3, 2018
- Business
- Vietnam Veterinary Products Joint Stock Co (UPCOM: VNY), operating as VINAVETCO, is a Vietnam-based company primarily engaged in the manufacturing, processing, importing, exporting, and distribution of veterinary pharmaceuticals, biologicals, and animal health nutritional products. Founded in 1955 and headquartered in Hanoi, Vietnam, the company operates within the agricultural and veterinary biotechnology sector, supplying commercial livestock producers, poultry farms, aquaculture enterprises, veterinary clinics, and retail pharmaceutical distributors nationwide and across Southeast Asian export markets.
The company offers a comprehensive portfolio of animal healthcare products organized into several key categories: veterinary pharmaceuticals, including injectable antibiotics, oral antibacterial powders, analgesics, anti-inflammatory agents, and anthelmintics such as amoxicillin, florfenicol, tylosin, enrofloxacin, and ivermectin formulations; animal biologicals and vaccines, covering preventive vaccines for swine fever, poultry pasteurellosis, Newcastle disease, infectious bronchitis, and avian viral infections; nutritional supplements and feed additives, comprising multi-vitamin premixes, amino acid complexes, digestive enzymes, electrolyte replenishments, and growth-promoting mineral blends; aquaculture health products, featuring water quality remediators, pond bio-disinfectants, and specialized aquatic metabolic enhancers; and farm biosecurity solutions, consisting of broad-spectrum chemical disinfectants, antiseptic sanitizers, and pest control agents for animal housing, hatcheries, and slaughterhouse facilities. In addition to primary manufacturing, the company provides diagnostic testing services, technical farm consultations, and custom pharmaceutical contract manufacturing for third-party agricultural brands.
In recent developments, Vietnam Veterinary Products Joint Stock Co has implemented strategic operational and product portfolio upgrades to align with evolving biosecurity standards and antibiotic reduction policies. The company has expanded its modern WHO-GMP, GLP, and GSP certified production facilities to scale the output of eco-friendly biologicals, natural herbal formulations, and probiotic-based feed supplements designed to replace conventional prophylactic antibiotics. To reinforce its commercial reach, VINAVETCO has restructured its distribution network, establishing direct strategic supply partnerships with large-scale industrial agribusiness conglomerates and high-tech farming cooperatives across Vietnam, while expanding export channels into regional markets including Cambodia and Laos. Furthermore, the company has integrated automated warehouse management systems and modernized its laboratory research infrastructure to accelerate the development of next-generation disease prevention solutions tailored to emerging livestock epidemics.